5-AZA-2'-deoxycytidine synergistic action with thymidine on leukemic cells and interaction of 5-AZA-dCMP with dCMP deaminase.
D000818:Animals; D001374:Azacitidine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000378:metabolism; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D003844:DCMP Deaminase / Q000378:metabolism*; D004273:DNA, Neoplasm / Q000096:biosynthesis; D000077209:Decitabine; D003845:Deoxycytosine Nucleotides / Q000378:metabolism; D004357:Drug Synergism; D006801:Humans; D008745:Methylation; D051379:Mice; D009709:Nucleotide Deaminases / Q000378:metabolism*; D013936:Thymidine / Q000008:administration & dosage*; D013942:Thymine Nucleotides / Q000378:metabolism
D004273:DNA, Neoplasm; D003845:Deoxycytosine Nucleotides; D013942:Thymine Nucleotides; C024107:2'-deoxycytidine 5'-triphosphate; C041519:5-aza-2'-deoxycytidine-5'-monophosphate; D000077209:Decitabine; D009709:Nucleotide Deaminases; D003844:DCMP Deaminase; D001374:Azacitidine; C024157:thymidine 5'-triphosphate; D013936:Thymidine